FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2963481056> ?p ?o ?g. }

• W2963481056 endingPage "1929" @default.
• W2963481056 startingPage "1917" @default.
• W2963481056 abstract "We analyzed data from 738 HER2-positive metastatic breast cancer (mbc) patients treated with pertuzumab-based regimens and/or T-DM1 at 45 Italian centers. Outcomes were explored in relation to tumor subtype assessed by immunohistochemistry (IHC). The median progression-free survival at first-line (mPFS1) was 12 months. Pertuzumab as first-line conferred longer mPFS1 compared to other first-line treatments (16 vs. 9 months, p = 0.0001), regardless of IHC subtype. Median PFS in second-line (mPFS2) was 7 months, with no difference by IHC subtype, but it was more favorable with T-DM1 compared to other agents (7 vs. 6 months, p = 0.03). There was no PFS2 gain in patients with tumors expressing both hormonal receptors (HRs; p = 0.17), while a trend emerged for tumors with one HR (p = 0.05). Conversely, PFS2 gain was significant in HRs-negative tumors (p = 0.04). Median overall survival (mOS) was 74 months, with no significant differences by IHC subtypes. Survival rates at 2 and 3 years in patients treated with T-DM1 in second-line after pertuzumab were significantly lower compared to pertuzumab-naïve patients (p = 0.01). When analyzed by IHC subtype, the outcome was confirmed if both HRs or no HRs were expressed (p = 0.02 and p = 0.006, respectively). Our results confirm that HRs expression impacts the clinical behavior and novel treatment-related outcomes of HER2-positive tumors when treatment sequences are considered. Moreover, multivariate analysis showed that HRs expression had no effect on PFS and OS. Further studies are warranted to confirm our findings and clarify the interplay between HER2 and estrogen receptor pathways in HER2-positive (mbc) patients." @default.
• W2963481056 created "2019-07-30" @default.
• W2963481056 creator A5002123343 @default.
• W2963481056 creator A5003744289 @default.
• W2963481056 creator A5003879120 @default.
• W2963481056 creator A5004091943 @default.
• W2963481056 creator A5004830992 @default.
• W2963481056 creator A5005520202 @default.
• W2963481056 creator A5008851608 @default.
• W2963481056 creator A5009199625 @default.
• W2963481056 creator A5010531543 @default.
• W2963481056 creator A5012187098 @default.
• W2963481056 creator A5013768705 @default.
• W2963481056 creator A5015192628 @default.
• W2963481056 creator A5017835821 @default.
• W2963481056 creator A5017982116 @default.
• W2963481056 creator A5018118709 @default.
• W2963481056 creator A5019053015 @default.
• W2963481056 creator A5020078965 @default.
• W2963481056 creator A5020324515 @default.
• W2963481056 creator A5020344479 @default.
• W2963481056 creator A5020843675 @default.
• W2963481056 creator A5022039294 @default.
• W2963481056 creator A5024258015 @default.
• W2963481056 creator A5025723323 @default.
• W2963481056 creator A5027075905 @default.
• W2963481056 creator A5027420799 @default.
• W2963481056 creator A5029630690 @default.
• W2963481056 creator A5032066996 @default.
• W2963481056 creator A5032805474 @default.
• W2963481056 creator A5034345931 @default.
• W2963481056 creator A5035471408 @default.
• W2963481056 creator A5038375887 @default.
• W2963481056 creator A5038529742 @default.
• W2963481056 creator A5038676900 @default.
• W2963481056 creator A5039800393 @default.
• W2963481056 creator A5040783792 @default.
• W2963481056 creator A5041223140 @default.
• W2963481056 creator A5041668420 @default.
• W2963481056 creator A5042210996 @default.
• W2963481056 creator A5042989547 @default.
• W2963481056 creator A5045083114 @default.
• W2963481056 creator A5045880854 @default.
• W2963481056 creator A5046176016 @default.
• W2963481056 creator A5048042450 @default.
• W2963481056 creator A5050187820 @default.
• W2963481056 creator A5050382848 @default.
• W2963481056 creator A5050912152 @default.
• W2963481056 creator A5051212202 @default.
• W2963481056 creator A5052593572 @default.
• W2963481056 creator A5052878762 @default.
• W2963481056 creator A5053974958 @default.
• W2963481056 creator A5054019294 @default.
• W2963481056 creator A5055332134 @default.
• W2963481056 creator A5057644746 @default.
• W2963481056 creator A5058082424 @default.
• W2963481056 creator A5059201916 @default.
• W2963481056 creator A5059504916 @default.
• W2963481056 creator A5060298494 @default.
• W2963481056 creator A5060428508 @default.
• W2963481056 creator A5061179981 @default.
• W2963481056 creator A5064997642 @default.
• W2963481056 creator A5065016800 @default.
• W2963481056 creator A5065153530 @default.
• W2963481056 creator A5065403219 @default.
• W2963481056 creator A5067689545 @default.
• W2963481056 creator A5068721926 @default.
• W2963481056 creator A5069924970 @default.
• W2963481056 creator A5070723634 @default.
• W2963481056 creator A5071785998 @default.
• W2963481056 creator A5072059804 @default.
• W2963481056 creator A5072619943 @default.
• W2963481056 creator A5072842070 @default.
• W2963481056 creator A5073978488 @default.
• W2963481056 creator A5075368412 @default.
• W2963481056 creator A5076498258 @default.
• W2963481056 creator A5077623457 @default.
• W2963481056 creator A5079245614 @default.
• W2963481056 creator A5079718032 @default.
• W2963481056 creator A5080721675 @default.
• W2963481056 creator A5085394100 @default.
• W2963481056 creator A5085432815 @default.
• W2963481056 creator A5087175612 @default.
• W2963481056 creator A5087862152 @default.
• W2963481056 creator A5088227859 @default.
• W2963481056 creator A5088488154 @default.
• W2963481056 creator A5091286114 @default.
• W2963481056 creator A5091765229 @default.
• W2963481056 date "2019-08-07" @default.
• W2963481056 modified "2023-09-30" @default.
• W2963481056 title "Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti‐HER2 agents in the real world setting" @default.
• W2963481056 cites W1595886999 @default.
• W2963481056 cites W1925211454 @default.
• W2963481056 cites W1967997862 @default.
• W2963481056 cites W1999997611 @default.
• W2963481056 cites W2063403350 @default.
• W2963481056 cites W2078140185 @default.
• W2963481056 cites W2095865154 @default.

• next